Chemomab Therapeutics
CMMB----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Chemomab Therapeutics(CMMB) predict that the EBIT is -1.85 M (+46.95%), Beat estimate;the EPS is -0.003 (+89.29%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.00B46.95%
-0.00B28.58%
+0.00B18.37%
EPSMiss expectations
-0.00389.29%
0100.00%
-0.003010.71%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf